News | June 04, 2012

Jury Awards $6.4 Million for Heart Attack Misdiagnosis

ER doctors misdiagnosed heart condition, released man with Motrin and antibiotic

June 4, 2012 — A jury awarded $6.4 million to the young children of a Philadelphia man after finding that emergency room doctors misdiagnosed a heart condition as pneumonia and discharged him from the hospital, only for him to die months later.

After seven days of testimony, the jury found that Robert M. McNamara, M.D., Marsha W. Edwards, M.D. and Temple University Hospital were negligent in the care of Derrick Harlem, 38. The verdict is believed to be among the largest Pennsylvania medical malpractice awards involving a death in years. Jurors reached the verdict three years to the day after Harlem's misdiagnosed heart condition.

"This is a fair and just verdict," said Matthew Casey, a founding partner at Ross Feller Casey, LLP, who litigated the case on behalf of Harlem's children. "These young children lost their dad and no amount of money can replace him. They would gladly give the money back for more time with their dad."

On May 31, 2009, Harlem passed out while playing basketball and was transported to the Temple University Hospital’s emergency department. Despite symptoms consistent with a heart attack, Harlem was diagnosed with pneumonia and released later that day after being given Motrin and Azithromycin.

Three months later, Harlem again passed out while playing basketball and was again taken to Temple's emergency department. This time, he had suffered a massive heart attack as a result of what had become a complete arterial blockage. Harlem remained in a pharmacologically induced coma until his death Nov. 12, 2009. He left behind five children, now ages 3-11.

The verdict includes $5.5 million for the loss of guidance, tutelage and moral upbringing.

For more information: www.rossfellercasey.com/practice-areas/medical-malpractice/


Related Content

News | Cath Lab

December 20, 2023 — Jason R. McCarthy, Ph.D., associate professor of biomedical research and translational medicine and ...

Home December 20, 2023
Home
News | Cath Lab

October 26, 2023 — Royal Philips, a global leader in health technology, announced the latest results demonstrating the ...

Home October 26, 2023
Home
News | Cath Lab

October 25, 2023 — Shockwave Medical, Inc., a pioneer in the development and commercialization of transformational ...

Home October 25, 2023
Home
News | Cath Lab

October 20, 2023 — Over the coming days, Philips will be presenting its latest solutions in cardiology and new late ...

Home October 20, 2023
Home
News | Cath Lab

October 16, 2023 — GE HealthCare (Nasdaq: GEHC) announced US FDA 510(k) clearance of Allia IGS Pulse - the latest ...

Home October 16, 2023
Home
News | Cath Lab

October 16, 2023 — Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, announced the first U.S ...

Home October 16, 2023
Home
News | Cath Lab

September 13, 2023 — A diagnostic test, first offered in the United States at University Hospitals (UH) Harrington Heart ...

Home September 13, 2023
Home
News | Cath Lab

August 2, 2023 — Teleflex Incorporated, a leading global provider of medical technologies, announced the U.S Food and ...

Home August 02, 2023
Home
News | Cath Lab

July 13, 2023 — Mount Sinai Queens announced the opening of a new cardiac catheterization lab that will provide rapid ...

Home July 13, 2023
Home
News | Cath Lab

June 21, 2023 — Royal Philips, a global leader in health technology, announced it has teamed up with BIOTRONIK (Lake ...

Home June 21, 2023
Home
Subscribe Now